Expression of vascular endothelial growth factor and angiopoietins in human corpus cavernosum
- 1 January 2010
- journal article
- Published by Wiley in BJU International
- Vol. 105 (2), 269-273
- https://doi.org/10.1111/j.1464-410x.2009.08663.x
Abstract
To evaluate the expression of the angiogenic factors vascular endothelial growth factor (VEGF) and angiopoietins (Ang) 1 and 2, in normal human penile erectile tissue.Penile fragments were removed from four young healthy organ donors (aged 17-28 years), and processed for immunohistochemical studies for VEGF, Ang1 and Ang2, and their specific receptors (VEGFR1 and 2, and Tie2, respectively). Molecular analysis was used to confirm the expression of VEGF and Angs in erectile tissue.VEGF and VEGFR1 expression was restricted to smooth muscle cells (SMCs). VEGFR2 was detected mainly in the endothelium lining and to a lesser extent in the SMC. Ang1 had a scattered distribution mostly in the perivascular SM layer, showing co-localization with VEGF. Tie2 was faintly detected in the endothelial cells. Ang2 was not detected by immunohistochemical studies, but the use of the same antibody in molecular analysis confirmed Ang2 expression in human corpus cavernosum.We show for the first time the co-localization of VEGF and Ang1 in the SMC, suggesting an interaction for vessel stabilization. Ang2 seems to be available for neoangiogenesis, if challenged. Studies of endothelial markers, growth factors and specific receptors are useful for understanding vascular organization and angiogenesis in normal human erectile tissue. This knowledge will be fundamental for developing newer therapeutic approaches to prevent or even cure erectile dysfunction.Keywords
This publication has 33 references indexed in Scilit:
- ED2: Erectile Dysfunction = Endothelial DysfunctionEndocrinology and Metabolism Clinics of North America, 2007
- Endothelial agingCardiovascular Research, 2005
- Erectile Dysfunction is a Marker for Cardiovascular Disease: Results of the Minority Health Institute Expert Advisory PanelThe Journal of Sexual Medicine, 2005
- Gene Therapy for Ischemic Cardiovascular Diseases: Some Lessons Learned from the First Clinical TrialsTrends in Cardiovascular Medicine, 2004
- Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZThe Journal of Gene Medicine, 2002
- Therapeutic Angiogenesis for Ischemic Cardiovascular DiseaseJournal of Molecular and Cellular Cardiology, 2001
- VEGF Gene Delivery to MyocardiumCirculation, 2000
- Hypoxia-Inducible Angiopoietin-2 Expression Is Mimicked by Iodonium Compounds and Occurs in the Rat Brain and Skin in Response to Systemic Hypoxia and Tissue IschemiaThe American Journal of Pathology, 2000
- Cell Type-Specific Expression of Angiopoietin-1 and Angiopoietin-2 Suggests a Role in Glioblastoma AngiogenesisThe American Journal of Pathology, 1998
- Vascular Endothelial Growth Factor/Vascular Permeability Factor Augments Nitric Oxide Release From Quiescent Rabbit and Human Vascular EndotheliumCirculation, 1997